SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  García Bermúdez, Mercedes ^a   López Mejías, Raquel ^b   Genre, Fernanda ^b   Castañeda, Santos ^c   González Juanatey, Carlos ^d   Llorca, Javier ^e   Corrales, Alfonso ^b   Miranda Filloy, José A ^f   Rueda Gotor, Javier ^b   Gómez Vaquero, Carmen ^g   Rodríguez Rodríguez, Luis ^h   Fernández Gutiérrez, Benjamín ^h   Pascual Salcedo, Dora ⁱ   Balsa, Alejandro ⁱ   López Longo, Francisco J ^j   Carreira, Patricia ^k   Blanco, Ricardo ^b   González Álvaro, Isidoro ^c   Martín, Javier ^a   González Gay, Miguel A ^b  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d Hospital Lucus Augusti   (Spain)

^e UNIVERSITY OF CANTABRIA   (Spain)

^f HOSPITAL XERAL CALDE   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j Hospital Universitario Gergorio Maranon   (Spain)

^k Hospital Universitario   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; SMAD3 PROTEIN;

ADULT; AGED; ALLELE; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTECTION; RHEUMATOID ARTHRITIS; RISK REDUCTION; SMAD3 GENE; SPAIN; SUBCLINICAL ATHEROSCLEROSIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SMAD3 PROTEIN; SPAIN; STROKE;

EID: 84886909282     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077695     Document Type: Article

References (32)

1. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J, (2005) Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35: 8-17. doi:10.1016/S0049-0172(05)00167-8. PubMed: 16084219.
2. Dessein PH, Norton GR, Woodiwiss AJ, Joffe BI, Wolfe F, (2007) Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 34: 943-951. PubMed: 17444592.
3. Rodríguez-Rodríguez L, López-Mejías R, García-Bermúdez M, González-Juanatey C, González-Gay MA, et al. (2012) Genetic markers of cardiovascular disease in rheumatoid arthritis. Mediat Inflamm, 2012(2012): 574817. PubMed: 22927710.
4. García-Bermúdez M, González-Juanatey C, López-Mejías R, Teruel M, Corrales A, et al. (2012) Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients. PLOS ONE 7: e49214. doi:10.1371/journal.pone.0049214. PubMed: 23166616.
5. López-Mejías R, García-Bermúdez M, González-Juanatey C, Castañeda S, Miranda-Filloy JA, et al. (2012) NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 224: 426-429. doi:10.1016/j.atherosclerosis.2012.06.008. PubMed: 22742859.
6. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453. doi:10.1056/NEJMoa072366. PubMed: 17634449.
7. Brown KA, Pietenpol JA, Moses HL, (2007) A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 101: 9-33. doi:10.1002/jcb.21255. PubMed: 17340614.
8. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, et al. (2008) Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9: 194-202. doi:10.1038/ni1549. PubMed: 18157133.
9. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, et al. (2008) The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 127: 89-97. doi:10.1016/j.clim.2008.01.009. PubMed: 18294918.
10. Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, et al. (2011) Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 4: 16-25. doi:10.1161/CIRCIMAGING.110.955351. PubMed: 21127203.
11. Lees CW, Barrett JC, Parkes M, Satsangi J, (2011) New IBD genetics: common pathways with other diseases. Gut 60: 1739-1753. doi:10.1136/gut.2009.199679. PubMed: 21300624.
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
13. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62: 2569-2581. doi:10.1002/art.27584. PubMed: 20872595.
14. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA, (2009) Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 38: 366-371. doi:10.1016/j.semarthrit.2008.01.012. PubMed: 18336869.
15. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, et al. (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57: 125-132. doi:10.1002/art.22482. PubMed: 17266100.
16. Ho KK, Pinsky JL, Kannel WB, Levy D, (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22: 6A-13A. doi:10.1016/0735-1097(93)90455-A. PubMed: 8376698.
17. Corrales A, González-Juanatey C, Peiró ME, Blanco R, Llorca J, et al. (2013) Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis. PubMed: 23505241.
18. Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay MA, (2006) Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum 55: 150-153. doi:10.1002/art.21707. PubMed: 16463428.
19. Naredo E, Möller I, Gutiérrez M, Bong DA, Cobo T, et al. (2011) Multi-examiner reliability of automated radio frequency-based ultrasound measurements of common carotid intima-media thickness in rheumatoid arthritis. Rheumatology (Oxf) 50: 1860-1864. doi:10.1093/rheumatology/ker206. PubMed: 21719420.
20. Semb AG, Rollefstad S, Provan SA, Kvien TK, Stranden E, et al. (2013) Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol 40: 359-368. doi:10.3899/jrheum.120621. PubMed: 23322468.
21. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340: 14-22. doi:10.1056/NEJM199901073400103. PubMed: 9878640.
22. Fox CS, Polak JF, Chazaro I, Cupples A, Wolf PA, et al. (2003) Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart Study. Stroke 34: 397-401. doi:10.1161/01.STR.0000048214.56981.6F. PubMed: 12574549.
23. Juo SH, Lin HF, Rundek T, Sabala EA, Boden-Albala B, et al. (2004) Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study. Stroke 35: 2243-2247. doi:10.1161/01.STR.0000142132.20442.d8. PubMed: 15331789.
24. Kerekes G, Soltész P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, et al. (2012) Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol 8: 224-234. doi:10.1038/nrrheum.2012.16. PubMed: 22349611.
25. Scott DL, Wolfe F, Huizinga TW, (2010) Rheumatoid arthritis. Lancet 376: 1094-1108. doi:10.1016/S0140-6736(10)60826-4. PubMed: 20870100.
26. Hansson GK, (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695. doi:10.1056/NEJMra043430. PubMed: 15843671.
27. López-Longo FJ, Oliver-Miñarro D, de la Torre I, de Rabago, Gonzalez-Diaz E, Sanchez-Ramon S,et al (2009) Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 61: 419-424. doi:10.1002/art.24390. PubMed: 19333979.
28. Willemze A, Trouw LA, Toes RE, Huizinga TW, (2012) The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol 8: 144-152. doi:10.1038/nrrheum.2011.204. PubMed: 22293763.
29. Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, et al. (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 52: 3433-3438. doi:10.1002/art.21385. PubMed: 16255021.
30. Viatte S, Plant D, Bowes J, Lunt M, Eyre S, et al. (2012) Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann Rheum Dis 71: 1984-1990. doi:10.1136/annrheumdis-2011-201225. PubMed: 22661644.
31. Daha NA, Toes RE, (2011) Rheumatoid arthritis: Are ACPA-positive and ACPA-negative RA the same disease? Nat Rev Rheumatol 7: 202-203. doi:10.1038/nrrheum.2011.28. PubMed: 21455249.
32. Viatte S, Plant D, Raychaudhuri S, (2013) Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol 9: 141-153. doi:10.1038/nrrheum.2012.237. PubMed: 23381558.